What Are the Results of the REVIVE-2 Trial?

Video
Conference|ID Week

David Huang, PhD, MD, shares the recent results of the REVIVE-2 trial.

David Huang, PhD, MD, chief medical officer at Motif Bio, shares the recent results of the REVIVE-2 trial.

Recent Videos
Related Content
Long-Acting Lenacapavir Shows Efficacy in Heavily Treatment-Experienced Patients

Long-Acting Lenacapavir Shows Efficacy in Heavily Treatment-Experienced Patients

Sophia Abene
November 11th 2024
Article
From Pathogen to Infectious Disease Diagnosis: Taking on Potential Standard-of-Care Diagnostic Opportunities

From Pathogen to Infectious Disease Diagnosis: Taking on Potential Standard-of-Care Diagnostic Opportunities

Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc
August 1st 2024
Podcast
Efficacy of HIV Combination Antiretroviral Medication in Black Individuals

Efficacy of HIV Combination Antiretroviral Medication in Black Individuals

Sophia Abene
November 7th 2024
Article
From Pathogen to Infectious Disease Diagnosis

From Pathogen to Infectious Disease Diagnosis

Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc
July 12th 2024
Podcast
Infection Control: AP Technology's Impact on Reducing HAIs and AMR Pathogens

Infection Control: AP Technology's Impact on Reducing HAIs and AMR Pathogens

Sophia Abene;Deborah (Debbi) Birx, MD;Amy Carenza, BBA
November 6th 2024
Article
INSPIRE Trials: Reducing Antibiotic Prescribing For Skin and Soft Tissue And Abdominal Infections

INSPIRE Trials: Reducing Antibiotic Prescribing For Skin and Soft Tissue And Abdominal Infections

Sophia Abene;Shruti K. Gohil, MD, MPH
November 6th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.